“Lazarus effect” in patient affected by lung adenocarcinoma carrying EGFR, CTNNB1, MET exon 11 and PIK3CA mutations treated with gefitinib

Nicole Conci, Filippo G. Dall’Olio, Vittoria Comellini, Stefano Brocchi, Rita Golfieri, Andrea Ardizzoni